Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
Titel:
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
Auteur:
Lee, Sung-Eun Lim, Ji-Young Ryu, Da-Bin Kim, Tae Woo Yoon, Jae-Ho Cho, Byung-Sik Eom, Ki-Seong Kim, Yoo-Jin Kim, Hee-Je Lee, Seok Cho, Seok-Goo Kim, Dong-Wook Lee, Jong-Wook Min, Woo-Sung Kim, Myungshin Min, Chang-Ki